Xtant Medical Inc. (XTNT)
Xtant Medical Statistics
Share Statistics
Xtant Medical has 139.32M shares outstanding. The number of shares has increased by 6.75% in one year.
| 139.32M |
| 6.75% |
| 0.04% |
| 71.57% |
| 115.47M |
| 4,271 |
| 2.27% |
Short Selling Information
The latest short interest is 24.19K, so 0.02% of the outstanding shares have been sold short.
| 24.19K |
| 0.02% |
| 0.06% |
| 1 |
Valuation Ratios
The PE ratio is -3.6 and the forward PE ratio is -32.5. Xtant Medical's PEG ratio is 0.
| -3.6 |
| -32.5 |
| 0.5 |
| 0.6 |
| 1.38 |
| -3.7 |
| 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Xtant Medical.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.82.
| 2.35 |
| 1 |
| 0.82 |
| -4.46 |
| -2.2 |
| -2.9 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $540,400.92 |
| $-75,801.84 |
| 217 |
| 1.25 |
| 1.27 |
Taxes
| 187K |
| -1.15% |
Stock Price Statistics
The stock price has increased by -16.11% in the last 52 weeks. The beta is -0.17, so Xtant Medical's price volatility has been lower than the market average.
| -0.17 |
| -16.11% |
| 0.56 |
| 0.53 |
| 46.72 |
| 188,436 |
Income Statement
In the last 12 months, Xtant Medical had revenue of 117.27M and earned -16.45M in profits. Earnings per share was -0.12.
| 117.27M |
| 68.22M |
| -12.07M |
| -16.45M |
| -7.88M |
| -12.1M |
| -0.12 |
Balance Sheet
The company has 6.2M in cash and 35.14M in debt, giving a net cash position of -28.94M.
| 6.2M |
| 35.14M |
| -28.94M |
| -259.46M |
| 95.83M |
| 39.56M |
Cash Flow
In the last 12 months, operating cash flow was -11.9M and capital expenditures -4.11M, giving a free cash flow of -16.01M.
| -11.9M |
| -4.11M |
| -16.01M |
| -0.12 |
Margins
Gross margin is 58.17%, with operating and profit margins of -10.3% and -14.03%.
| 58.17% |
| -10.3% |
| -13.87% |
| -14.03% |
| -6.72% |
| -10.3% |
| -13.65% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for XTNT is $3, which is 376.2% higher than the current price. The consensus rating is "Strong Buy".
| $3 |
| 376.2% |
| Strong Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Feb 14, 2018. It was a backward split with a ratio of 1:12.
| Feb 14, 2018 |
| backward |
| 1:12 |
Scores
| -1.15 |
| 3 |